Literature DB >> 7230834

A model of tumor cell dormancy: effects of anesthesia and surgery.

J Varani, E J Lovett, J Lundy.   

Abstract

Three cloned populations of tumor cells obtained from a murine fibrosarcoma were able to remain viable for a long period of time in syngeneic mice which failed to exhibit clinically evident tumors following tumor cell inoculation. Viable tumor cells under such conditions can be considered to be in a dormant state. On the basis of past studies, two of the lines were shown to have low malignant potential, while the third line was shown to have a higher degree of malignant potential. The rates of spontaneous reactivation of tumor growth in animals carrying the low malignant cells were 3 and 4%, while a rate of 30% was observed in animals with the more malignant cells. Treatment of animals carrying the low malignant cells in a dormant state with anesthesia alone, (thiopental) or with anethesia and surgery, increased the rate of reactivation to 20-22%.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7230834     DOI: 10.1002/jso.2930170103

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?

Authors:  Philippe Hernigou; Charles Henri Flouzat Lachaniette; Jerome Delambre; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-06-07       Impact factor: 3.075

2.  Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

Authors:  Pierre Perrot; Julie Rousseau; Anne-Laure Bouffaut; Françoise Rédini; Elisabeth Cassagnau; Frédéric Deschaseaux; Marie-Françoise Heymann; Dominique Heymann; Franck Duteille; Valérie Trichet; François Gouin
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

Review 3.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

4.  Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer.

Authors:  Hongyun Zhao; Yan Huang; Cong Xue; Yang Chen; Xue Hou; Ying Guo; Liping Zhao; Zhi huang Hu; Yujie Huang; Yongzhang Luo; Li Zhang
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

5.  Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape?

Authors:  William W Tseng; Niloofar Fadaki; Stanley P Leong
Journal:  Cancers (Basel)       Date:  2011-02-21       Impact factor: 6.639

6.  Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.

Authors:  Jian-fei Zhu; Xing-yu Feng; Xue-wen Zhang; Ying-sheng Wen; Peng Lin; Tie-hua Rong; Ling Cai; Lan-jun Zhang
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.